CARB-X announced today that it’s awarding $1.2 million to a research team at Harvard University to develop enhanced antibiotics for multidrug-resistant bacteria.

Researchers report that photodynamic therapy increases antibiotic penetration and disrupts resistance mechanisms in laboratory strains.

Physicians have relied on a class of antibiotics called polymyxins to fight potentially life-threatening Gram-negative bacterial infections for more than 80 years. These drugs are typically reserved ...

GARDP has acquired all data and licensing rights for apramycin, an aminoglycoside antibiotic used in veterinary medicine, and will evaluate its potential to treat highly drug-resistant infections in ...

• Require X (hemin) and/or V (nicotinamide adenine dinucleotide) factors for growth • Responsible for 0.5–1% of all cases of IE • Haemophilus aphrophilus is the most common species responsible for IE ...

Researchers have developed a new antibiotic that reduced or eliminated drug-resistant bacterial infections in mouse models of acute pneumonia and sepsis while sparing healthy microbes in the mouse gut ...

The emergence of multi-drug resistance bacteria and healthcare-associated infections are frequent issues in the treatment of suppurating wounds. A group of researchers has created a bactericidal ...

BRD is often framed as stress, viruses and bacteria. Managing inflammation tied to endotoxin helps explain why some cattle recover faster than others ...

BV100 Phase 1, single- and multiple-ascending dose clinical trial data include pharmacokinetics, safety and tolerability data. BV100 demonstrated a dose-proportional pharmacokinetic profile and was ...